These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

The firms expect that by expanding manufacturing capacity they can double the sales volume of Carvykti from 10,000 doses in 2025 to 20,000 doses in 2027.

The team from The Scripps Research Institute and Janssen Pharmaceutical Companies designed a molecule that mimicked the shape of a key part of the influenza virus, inducing a powerful and broadly ...

Siltuximab effectively treated patients who experienced common adverse events after chimeric antigen receptor T-cell therapy, ...

Four biosimilars for Stelara have launched in the United States this year following legal settlements with the reference ...

Janssen has entered into a collaboration agreement with Phenex Pharmaceuticals AG, a German drug discovery company that focuses on developing innovative small molecule therapeutics, in the fields ...

Going deeper in MM science. Together with Legend Biotech, Janssen is developing a CAR-T cell therapy in MM. Janssen views this single asset collaboration as a foundational component of potential ...